Arcadia Biosciences, Inc. (RKDA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Arcadia Biosciences, Inc. on August 7, 2026, regarding an event reported on August 4, 2026. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market under the symbol "RKDA".
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes and Listing Status
On August 4, 2026, the Company received a notice from Nasdaq stating it is not in compliance with the minimum bid price requirement (Rule 5550(a)(2)).
- Deficiency: The closing bid price of the Common Stock was below $1.00 per share for 30 consecutive business days (June 22, 2026, to August 3, 2026).
- Immediate Effect: The stock will continue to trade on Nasdaq under the symbol "RKDA" with no immediate suspension.
- Compliance Period: The Company has an initial 180-day period (until February 1, 2027) to regain compliance.
- Requirement to Cure: The closing bid price must meet or exceed $1.00 per share for at least ten consecutive business days during the compliance period.
Outlook, Risks, and Management Commentary
Management intends to actively monitor the stock price and evaluate options to regain compliance, including the potential implementation of a reverse stock split if necessary.
- Future Compliance: If the Company fails to comply by February 1, 2027, it may be eligible for an additional 180-day period if it meets other listing standards (e.g., market value of publicly held shares).
- Delisting Risk: If the Company is not eligible for an additional period or cannot cure the deficiency, Nasdaq may initiate delisting proceedings. The Company would have the right to appeal such a determination.
- Uncertainty: There is no assurance that the Company will regain compliance or maintain other listing requirements.
Key Facts for Investor Verification
- Verify the current trading price of RKDA relative to the $1.00 minimum bid price threshold.
- Monitor the Company's announcements regarding the potential execution of a reverse stock split.
- Track the Company's progress toward maintaining a $1.00+ closing bid price for ten consecutive days before the February 1, 2027 deadline.
- Review subsequent filings for any updates on the Company's market value of publicly held shares, which is a prerequisite for a second compliance period.